Showing results (151-160 of 176) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor CellsBen-Yuan Jiang, Yang-Si Li, Wei-Bang Guo, et al.Signal Transduction and Targeted Therapy|February 23, 2023
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trialWen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen, et al.Journal of Translational Medicine|April 2, 2024
Correlation of distribution characteristics and dynamic changes of gut microbiota with the efficacy of immunotherapy in EGFR-mutated non-small cell lung cancerWei-Chi Luo, Shi-Qi Mei, Zi-Jian Huang, et al.Frontiers in Immunology|October 20, 2022
PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinomaYu-Min Zhong, Kai Yin, Yu Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2021
A Novel Third-generation EGFR Tyrosine Kinase Inhibitor Abivertinib for EGFR T790M-mutant Non-Small Cell Lung Cancer: a Multicenter Phase I/II StudyQing Zhou, Lin Wu, Pei Hu, et al.Signal Transduction and Targeted Therapy|December 6, 2023
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II studySi-Yang Liu, Song Dong, Xue-Ning Yang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2017
Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung CancerAnna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.Journal of Hematology & Oncology|April 17, 2020
Association of genetic and immuno-characteristics with clinical outcomes in patients with RET-rearranged non-small cell lung cancer: a retrospective multicenter studyChang Lu, Xiao-Rong Dong, Jun Zhao, et al.The Lancet. Respiratory Medicine|July 26, 2024
Foritinib in advanced ROS1-rearranged non-small-cell lung cancer in China: a multicentre, open-label, single-arm, phase 2 studyJin-Ji Yang, Jianying Zhou, Si-Yang Maggie Liu, et al.Lung Cancer (Amsterdam, Netherlands)|November 28, 2017
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancerHai-Yan Tu, E-E Ke, Jin-Ji Yang, et al.Pageof 18